Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-23
1994-02-15
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544 92, 544283, 544284, 544287, A61K 31505, C07D40114, C07D40112, C07D40512
Patent
active
052867293
ABSTRACT:
The invention provides novel 2,3,6 substituted quinazolinones having the formula ##STR1## wherein R, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and X are described in the specification which have activity as angiotensin II (AII) antagonists.
REFERENCES:
patent: 5162325 (1992-11-01), Chakravarty et al.
patent: 5202322 (1993-04-01), Allen et al.
patent: 5204354 (1993-04-01), Chakravarty et al.
Levin Jeremy I.
Venkatesan Aranapakam M.
American Cyanamid Company
Bernhardt Emily
Szatkowski Thomas S.
LandOfFree
Angiotensin II receptor blocking 2,3,6 substituted quinazolinone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor blocking 2,3,6 substituted quinazolinone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor blocking 2,3,6 substituted quinazolinone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1207184